DR ZEESHAN BADAR , DR SHEIKH TAHIR SIDDIQUE , DR ZIAUDDIN AHMED , DR ABDUL SAMAD SHAIKH , DR ABDUL GHAFFAR SHAIKH , DR FARYAL AZHAR. EFFICACY AND SAFETY OF RITUXIMAB PLUS DOSE ADJUSTED ETOPOSIDE, PREDNISONE, VINCRISTINE, CYCLOPHOSPHAMIDE AND DOXORUBICIN (R-DA-EPOCH) REGIMEN IN HIGH GRADE DIFFUSE LARGE B- CELL LYMPHOMA PATIENTS (HG-DLBCL). TPM [Internet]. 2025 Nov. 5 [cited 2026 Jan. 30];32(S8 (2025): Posted 05 November):2910-5. Available from: https://tpmap.org/submission/index.php/tpm/article/view/4054